Some IUDs of the Ancora and Novaplus brands, the marketing of which has already been suspended since November 2019, must be withdrawn preventively, "without urgency", in particular because of a risk of spontaneous expulsion, the Medicines Agency (ANSM) indicates on Tuesday. .
This decision concerns a maximum of 40,000 women in France, carriers of IUDs of these two brands of the Spanish manufacturer Eurogine, installed mainly in 2017 and 2018, and "until March 2019", specifies the ANSM.
"It is a precautionary measure, without urgency, to be planned during the next consultation with his gynecologist", his general practitioner or his midwife, explained Thierry Thomas, deputy director of the ANSM in charge of medical devices.
Read alsoContraception: all you need to know about the IUD
On the other hand, "in the event of evocative signs" of expulsion (abdominal pain, bleeding out of period, absent or too long traction thread, pain during sexual intercourse ...), the women concerned must "have the reflex to go to consult immediately. », He clarified.
The main risk associated with this lack of stability is the ineffectiveness of the IUD as a means of contraception, which can lead to unwanted pregnancies.
Don't wait three years
A recommendation had already been made to remove these IUDs after three years, as the majority of reported expulsions occurred after that time.
But the ANSM now recommends removing the intrauterine devices (IUD) concerned without waiting three years.
Indeed, "numerous reports, in particular of pregnancy or spontaneous expulsion, continue to be reported to the ANSM concerning Ancora or Novaplus models having been installed until March 2019", explains the health products policeman.
March 2019 corresponds to the last recall of the affected products implemented by their French distributor, so it is “the last possible date when the IUDs could have been fitted” concerned, underlines Thierry Thomas.
A withdrawal that requires precautions
This communication is also an opportunity to remind those who have had this model for more than three years but have not yet withdrawn the recommendation.
Due to an increased risk of breakage during removal, healthcare professionals responsible for gynecological monitoring (gynecologists, general practitioners and midwives) are advised to proceed with caution.
“Perform a slow and constant pull by pulling the wires, then visually check the integrity of the device once removed.
(…) In the event of a rupture and the persistence of a fragment inside the uterus, perform an ultrasound after the next menstruation (the residual fragment can be expelled during menstruation) ”, explains in particular the document detailing the recommendations.
Eurogine represented “around 5% of IUD sales in France until 2017”, or some 20,000 devices per year, a proportion which then fell to 3% in 2018, said Thierry Thomas.
